The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions

Transplantation

Volumn 69, Issue 3, 2000, Pages 411-417

  Niimi, Masanori ^a   Roelen, Dave L ^b   Witzke, Oliver ^a   Van Rood, Jon J ^c   Claas, Frans H J ^b   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Europdonor Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; GRAFT SURVIVAL; HAPLOTYPE; HEART TRANSPLANTATION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL;

EID: 0033996336     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002150-00018     Document Type: Article

References (47)

1. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608.
2. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
3. Ting A, Morris PJ. The influence of HLA-A,B and -DR matching and pregraft blood transfusions on graft and patient survival after renal transplantation in a single centre. Tissue Antigens 1984; 24: 256.
4. Opelz G, and Collaborative Transplant Study. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants. Transplant Proc 1987; 19: 641.
5. Iwaki Y, Cecka JM, Terasaki PI. The transfusion effect. Clin Transplant 1988; 283.
6. Cicciarelli J. UNOS Registry data: effect of transfusions. Clin Transplant 1990; 407.
7. Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997; 63: 964.
8. Van Rood JJ, Claas FHJ. The influence of allogeneic cells on the human T and B cell repertoire. Science 1990; 248: 1388.
9. Sheng-Tanner X, Miller RG. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J Exp Med 1992; 176: 407.
10. Salvatierra O, Melzer J, Vincenti F, et al. Donor-specific blood transfusions versus cyclosporine: the DST story. Transplant Proc 1987; 19: 160.
11. Burlingham WJ, Grailer AP, Fechner JH, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995; 59: 1147.
12. Lagaaij EL, Hennemann IPH, Ruigrok MB, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
13. Lagaay EL, Ruigrok MB, Van Rood JJ, et al. Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. J Immunol 1991; 147: 3348.
14. Roelen DL, Dover EL, Niimi M, Young NT, Morris PJ, Wood KJ. Semiallogeneic (F1) versus fully allogeneic blood transfusions: differences in their ability to induce specific immunological unresponsiveness. Eur J Immunol 1996; 26: 1468.
15. Corry R J, Winn H, Russell P. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
16. Superina RA, Peugh WN, Wood KJ, Morris PJ. Assessment of primarily vascularized cardiac allografts in mice. Transplantation 1986; 42: 226.
17. Wood ML, Gottschalk R, Monaco AP. Immune reactivity in congenic mice after allogeneic or isogeneic transfusion. Transplantation 1986; 41: 489.
18. Turka LA, Tanaka K, Kupiec-Weglinski JW, Milford EL, Tilney NL, Carpenter CB. In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. Transplantation 1989; 47; 388.
19. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
20. Van Twuyver E, Kast WM, Mooyaart RJD, Wilmink JM, Melief CJM, De Waal LP. Allograft tolerance induction in adult mice associated with functional deletion of specific CTL precursors. Transplantation 1989; 48: 844.
21. Marquet RL, Heystek GA, Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats. Transplantation 1981; 31: 272.
22. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
23. Rammensee H-G, Fink PJ, Bevan MJ. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J Immunol 1984; 133: 2390.
24. Heeg K, Wagner H. Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2 T cells. J Exp Med 1990; 172: 719.
25. Miller RG, Phillips RA. Reduction of the in vitro cytotoxic lymphocyte response produced by in vivo exposure to semiallogeneic cells: recruitment or active suppression? J Immunol 1976; 117: 1913.
26. Ishikawa H, Hino T, Kato H, Suzuki H, Saito K. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen. J Immunol 1986; 137: 2080.
27. Sato S, Azuma T, Shimizu J, et al. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset: abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells. J Immunol 1988; 141: 721.
28. Martin DR, Miller RG. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med 1989; 170: 679.
29. Kiziroglu F, Miller RG. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells. J Immunol 1991; 146: 1104.
30. Middleton D, Martin J, Douglas J, McClelland M. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994; 58: 845.
31. Bayle F, Masson D, Zaoui P, et al. Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59: 719.
32. Van der Mast BJ, Balk AH. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. Transplantation 1997; 63: 1514.
33. Wood PJ, Streilein JW. Immunogenetic basis of acquired transplantation tolerance. Transplantation 1984; 37: 223.
34. Cecka JM, Cicciarelli J, Mickey MR, Terasaki PI. Blood transfusions and HLA matching: an either/or situation in cadaveric renal transplantation. Transplantation 1988; 45: 81.
35. Lazda VA, Pollak R, Mozes MF, Barber PL, Jonasson O. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Transplantation 1990; 49: 1084.
36. Bell Y, Shoskes D, Morris P, Wood K. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo. Transplant Proc 1993; 25: 359.
37. Mincheff MS, Meryman HT, Kapoor V, Alsop P. Wotzel M. Blood transfusion and immunomodulation: a possible mechanism. Vox Sang 1993; 65: 18.
38. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996; 101: 299.
39. Toungouz M, Denys C, de Groote D, Andrien M, Dupont E. Optimal control of interferon-gamma and tumor necrosis factor-alpha by interleukin-10 produced in response to one HLA-DR mismatch during the primary mixed lymphocyte reaction. Transplantation 1996; 61: 497.
40. Reed E, Hardy M, Benvenisty A, et al. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med 1987; 316: 1450.
41. Terasaki PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 1984 17: 119.
42. Hutchinson IV. Suppressor T cells in allogeneic models. Transplantation 1986 41: 547.
43. Roelen DL, Bushell AR, Niimi M, et al. Immunoregulation by CD4 T cells in the induction of specific immunological unresponsiveness to alloantigens in vivo: evidence for a reduction in the frequency of alloantigen-specific cytotoxic T cells in vitro. Hum Immunol 1998; 59: 529.
44. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation. 1997; 63: 1490.
45. Davies JD, Leong LYW, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602.
46. Hoyne GF, Lamb JR. Regulation of T cell function in mucosal tolerance. Immunol Cell Biol 1997; 75: 197.
47. Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998; 4: 1251.